Humacyte, Inc. (NASDAQ:HUMA) CEO Laura E. Niklason Sells 2,625,000 Shares
Humacyte, Inc. (NASDAQ:HUMA – Get Rating) CEO Laura E. Niklason sold 2,625,000 shares of the company’s stock in a transaction that occurred on Thursday, May 25th. The stock was sold at an average price of $2.75, for a total transaction of $7,218,750.00. Following the completion of the sale, the chief executive officer now directly owns […]